Phase II study with prolonged infusion gemcitabine in pretreated advanced soft tissue sarcomas of the adult

被引：1
|
作者：
Späth-Schwalbe, E
Genvresse, I
Koschuth, A
Grunewald, R
Possinger, K
机构：
[1] Charite Univ Hosp, Berlin, Germany
[2] Humboldt Univ, Berlin, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81503-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1083
引用
收藏
页码：S271 / S271
页数：1
相关论文
共 50 条
  • [1] Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas
    Späth-Schwalbe, E
    Genvresse, I
    Koschuth, A
    Dietzmann, A
    Grunewald, R
    Possinger, K
    [J]. ANTI-CANCER DRUGS, 2000, 11 (05) : 325 - 329
  • [2] Gemcitabine in advanced adult soft-tissue sarcomas.: A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group
    Svancárová, L
    Blay, JY
    Judson, IR
    van Hoesel, QGCM
    van Oosterom, AT
    le Cesne, A
    Keizer, HJ
    Hermans, C
    van Glabbeke, M
    Verweij, J
    Hogendoorn, PCW
    Nielsen, OS
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 (04) : 556 - 559
  • [3] Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas
    Losa, R.
    Fra, J.
    Lopez-Pousa, A.
    Sierra, M.
    Goitia, A.
    Una, E.
    Nadal, R.
    del Muro, J. Garcia
    Gion, M.
    Maurel, J.
    Escudero, P.
    Esteban, E.
    Buesa, Jose M.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (02) : 251 - 259
  • [4] Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas
    R. Losa
    J. Fra
    A. López-Pousa
    M. Sierra
    A. Goitia
    E. Uña
    R. Nadal
    J. García del Muro
    M. Gión
    J. Maurel
    P. Escudero
    E. Esteban
    José M. Buesa
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 59 : 251 - 259
  • [5] Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas
    Palumbo, R
    Palmeri, S
    Antimi, M
    Gatti, C
    Raffo, P
    Villani, G
    Toma, S
    [J]. ANNALS OF ONCOLOGY, 1997, 8 (11) : 1159 - 1162
  • [6] Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas
    Hartmann, JT
    Oechsle, K
    Mayer, F
    Kanz, L
    Bokemeyer, C
    [J]. ANTICANCER RESEARCH, 2003, 23 (2C) : 1899 - 1901
  • [7] Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study
    A López-Pousa
    R Losa
    J Martín
    J Maurel
    J Fra
    M Sierra
    A Casado
    J García del Muro
    A Poveda
    C Balañá
    J Martínez-Trufero
    E Esteban
    J M Buesa
    [J]. British Journal of Cancer, 2006, 94 : 1797 - 1802
  • [8] Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas:: a GEIS study
    Lopez-Pousa, A.
    Losa, R.
    Martin, J.
    Maurel, J.
    Fra, J.
    Sierra, M.
    Casado, A.
    Garcia del Muro, J.
    Poveda, A.
    Balana, C.
    Martinez-Trufero, J.
    Esteban, E.
    Buesa, J. M.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (12) : 1797 - 1802
  • [9] Phase II study of docetaxel in advanced soft tissue sarcomas
    Edmonson, JH
    Ebbert, LP
    Nascimento, AG
    Jung, SH
    McGaw, H
    Gerstner, JB
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (06): : 574 - 576
  • [10] Doxorubicin (DXR) and prolonged infusion gemcitabine (GMC) as first-line treatment in advanced soft tissue sarcomas (STS).: A phase II trial of the Spanish Group for Research in Sarcomas (GEIS).
    Lopez-Pousa, A
    Buesa, J
    Casado, A
    Del Muro, JG
    Poveda, A
    Maurel, J
    Martin, J
    Balaña, C
    Martinez, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 826S - 826S
12345